Literature DB >> 12930503

Effective long-term left atrial pacing using regular screw-in leads implanted within the coronary sinus.

Sana Ouali1, Frédéric Anselme, Françoise Hidden, Arnaud Savouré, Alain Cribier, Nadir Saoudi, Robert Frank.   

Abstract

Passive-fixation leads positioned inside the coronary sinus (CS) have been found to be effective in LA pacing and sensing, but their use is limited by a high incidence of early and late dislodgment. Since anatomic studies have shown that the proximal part of the CS is surrounded by a relatively thick musculature, the feasibility, safety, and efficacy of acute and chronic coronary sinus pacing via regular screw-in leads positioned within the first centimeters of the CS were evaluated as compared to passive-fixation leads. Thirty-three patients (21 men, age 62 +/- 10 years) underwent dual chamber pacemaker implantation with LA pacing obtained via passive-fixation leads (7 patients) or regular screw-in leads (26 patients). The former approach was prematurely abandoned because of a high rate of acute and late lead dislodgment (42%). The chronic pacing threshold was 1.7 +/- 1.0 V at 0.67-ms pulse width and 1.47 +/- 1.3 V at 0.5-ms pulse width for passive- and active-fixation leads, respectively. In the CS active-fixation lead group, no postoperative pericardial effusion, CS lead dislodgment, nor diaphragmatic stimulation were observed. In this last group, steroid eluting leads (14 patients) have a statistically lower pacing threshold than noneluting steroid leads (12 patients) (0.88 +/- 0.23 vs 2.29 +/- 1.68 V, P = 0.011) at long-term follow-up. The use of regular screw-in leads implanted within the CS allows effective and safe long-term LA pacing without risk of dislodgment.

Entities:  

Mesh:

Year:  2003        PMID: 12930503     DOI: 10.1046/j.1460-9592.2003.t01-1-00283.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  1 in total

1.  Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.

Authors:  Tanwier T T K Ramdjan; Lisette J M E van der Does; Paul Knops; Jan C J Res; Natasja M S de Groot
Journal:  Trials       Date:  2014-11-17       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.